Drug
Efgartigimod Administration
Efgartigimod Administration: highest development phase Phase 3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| efgartigimod administration NCT06765161 | Phase 3 | Myasthaenia Gravis |
Latest
No recent events.
Follow Efgartigimod Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.